Alaska (AK) Commercial Law CLE Course Catalog

Litigation regarding per- and polyfluoroalkyl substances has continued to evolve, from product liability to environmental litigation to consumer class actions. Recent and forthcoming regulations continue to add new dimensions, potentially impacting multiple areas of legal practice and a variety of industries. Particularly, these claims have reached across the supply chain, including retailers and distributors, with novel legal theories, further underscoring the need to stay abreast for recent trends in this area.

Join Karl P. Frederic of Windels Marx and Whitney Hodges of Sheppard Mullin in this CLE webcast as they unveil the essential legal and business fundamentals crucial for success in this rapidly expanding industry.

Listen as experienced cannabis consultants and lawyers Whitney Hodges (Sheppard Mullin) and Shay Aaron Gilmore (The Law Office of Shay Aaron Gilmore) provide the audience with a comprehensive discussion of the current regulatory developments in the cannabis industry as well as the surrounding issues that legal practitioners should be wary of. Speakers, among other things, will offer practical tips and strategies to navigate this rapidly evolving legal climate.

As the COVID-19 crisis stretches into its third year, brands and generic drug companies will likely see the impact of continued regulatory developments in the Hatch-Waxman space. Moreover, recent notable cases further reveal key takeaways and unresolved issues which drug companies should be wary of. Among the salient developments involve changes in venue for a Hatch-Waxman Act case — highlighting the need for concerned practitioners to stay close to the venue issue as it remains to be a focus of the Federal courts. In this program, a panel of key thought leaders and practitioners will offer an in-depth look at the critical developments and issues surrounding Hatch-Waxman litigation. This course will provide helpful insights to help your company deal with patent challenges.

While the amendments brought by the CPRA aim to strengthen consumer privacy rights, these also make compliance more challenging as additional requirements and tighter rules related to the collection and sale of personal information take effect. Having impact on both California and international consumer data processing, businesses need to take extra steps to maintain compliance and effective data privacy operations. In this program, data protection and privacy professionals will provide an in-depth discussion of the California Privacy Rights Act (CPRA). The speakers will dissect every emerging development and its implication on businesses and the general compliance practices.

Chapter 11 doesn’t work for every corporate liquidation. This panel of experts will discuss other ways a corporation can be liquidated, including out-of-court liquidations, receiverships, ABCs, the Delaware Dissolution Statute and chapter 7.

Chapter 11 doesn’t work for every corporate liquidation. This panel of experts will discuss other ways a corporation can be liquidated, including out-of-court liquidations, receiverships, ABCs, the Delaware Dissolution Statute and chapter 7.

This panel will focus on the immediate and continuing repercussions of the COVID-19 pandemic on the economy, with a focus on macroeconomic effects, how businesses have been affected, what efforts have been made by the federal government through various stimulus and relief packages, and what to expect in the future.

Uncle Sam said “Take the money...everything will be OK”. Now, the IRS, SBA and Congress are changing the rules, creating new hurdles for distressed businesses. This panel dives into recent legislation in CARES II and the evolving legal and regulatory landscape governing access to, and repayment of, PPP and EIDL loans.